CMap Candidate Details
Structure:
| CMap ID: | C01502 |
| Pert ID: | BRD-A63043573 |
| Compound Name: | cabergoline |
| Targets: | ADRA1A; ADRA2A; ADRA2B; ADRA2C; DRD1; DRD2; DRD3; DRD4; DRD5; HTR1A; HTR1B; HTR1D; HTR2A; HTR2B; HTR2C |
| MoA: | Dopamine receptor agonist |
| SMILES: | CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(Cc3c[nH]c4cccc2c34)N(CC=C)C1 |
| InchiKey: | KORNTPPJEAJQIU-UHFFFAOYSA-N |
| Compound Aliases: | -- |
| Score ID | Pert ID | Cell Line | Pert Dose | Pert Time | Raw Score (GSE126848) | Normalized Score (GSE126848) | fdr_q_nlog10 (GSE126848) | Raw Score (GSE135251) | Normalized Score (GSE135251) | fdr_q_nlog10 (GSE135251) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2814 | BRD-A63043573 | HA1E | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 3113 | BRD-A63043573 | HCC515 | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 3586 | BRD-A63043573 | PC3 | 10 uM | 6 h | 0.0 | 0.0 | 0.0 | -0.28 | -0.94 | 0.38 |
| 3928 | BRD-A63043573 | VCAP | 10 uM | 6 h | -0.23 | -0.98 | 0.11 | -0.31 | -1.06 | 0.72 |
| 39053 | BRD-A63043573 | A375 | 10 uM | 6 h | -0.19 | -0.8 | 0.0 | -0.3 | -1.0 | 0.52 |
| 39402 | BRD-A63043573 | A549 | 10 uM | 6 h | 0.0 | 0.0 | 0.0 | -0.23 | -0.77 | 0.08 |
| 39576 | BRD-A63043573 | ASC | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | -0.27 | -0.92 | 0.32 |
| 39901 | BRD-A63043573 | HEPG2 | 10 uM | 6 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 40185 | BRD-A63043573 | HT29 | 10 uM | 6 h | -0.3 | -1.24 | 0.67 | -0.28 | -0.94 | 0.39 |
| 40571 | BRD-A63043573 | MCF??7.00 | 10 uM | 6 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 40703 | BRD-A63043573 | NEU | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | -0.3 | -1.0 | 0.54 |
| 41002 | BRD-A63043573 | NPC | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 41325 | BRD-A63043573 | SKB | 10 uM | 24 h | 0.0 | 0.0 | 0.0 | 0.33 | 1.17 | 0.95 |